In the present study we measured fasting lipid profiles in over 8,500
community-living men with coronary artery disease (CAD) to determine t
he distribution of lipid abnormalities in this population: 81% were wh
ite and 16% black,; mean age 62.9 +/- 8 years; mean total cholesterol
214 +/- 41 mg/dl; low-density lipoprotein (LDL) cholesterol 140 +/- 37
mg/dl; high-density lipoprotein (HDL) cholesterol 39 +/- 11 mg/dl; an
d triglycerides 190 +/- 142 mg/dl. After adjusting for age, the only s
ignificant difference between blacks and whites was a higher HDL chole
sterol in blacks (45 vs 38 mg/dl, p <0.003). With use of cut points es
tablished by the National Cholesterol Education Program, 87% of subjec
ts had high LDL cholesterol (greater than or equal to 100 mg/dl), 38%
had HDL cholesterol (<35 mg/dl), and 33% had high triglycerides (>200
mg/dl). We estimated that 42% of men with CAD would be definite candid
ates for cholesterol-lowering medication according to the National Cho
lesterol Education Program guidelines and that 41% of those in whom ch
olesterol-lowering medication would not be definitely indicated had lo
w levels of HDL cholesterol. We conclude that (1) black men with CAD h
ave substantially higher HDL cholesterol than white men, (2) almost 90
% of male patients with CAD are candidates for dietary intervention an
d >40% may need medications to lower LDL cholesterol, and (3) 40% of p
atients without a definite indication for cholesterol-lowering medicat
ions have low levels of HDL cholesterol.